international conference on harmonization
-
-
Recently, the US Food and Drug Administration (FDA) and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) launched a quality-by-design initiative that encourages new drug applications to include a design space and risk-based control strategies. The FDA also encourages the application of simulation experiments, Bayesian adaptive designs and data-mining techniques in the critical path of research investigating efficacy and safety of new drug products. The aim of pharmaceutical development is to design a quality, safe and effective product with consistent and economical manufacturing processes. The achievement of quality requires an increase in management maturity and a comprehensive, integrated view in...
-
-
-
... the Declaration of Helsinki and International Conference on Harmonization (ICH) and Good Clinica...
-
-
-
SILVER SPRING, Md., March 16, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration and the European Medicines Agency (EMA) have launched a new pilot program that will allow parallel evaluation of relevant development and manufacturing data components, known as Quality by Design (QbD), of new drug marketing applications that are submitted to both agencies.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)
... have been developed by the International Conference on Harmonisation (ICH) to harmonize and...International Conference on Harmonization - Quality Guidance. European Medicines Agency. Int...
-
-